CAAX-dependent modifications of the lamin proteins in the organization of the nuclear periphery
Maske, C.P.; Vaux, D.J.
Symposia of the Society for Experimental Biology 56: 317-328
2004
ISSN/ISBN: 0081-1386 PMID: 15565890 Document Number: 583526
Document emailed within 1 workday
Related Documents
Landesman, Y.; Pagano, M.; Draetta, G.; Rotter, V.; Fusenig, N.E.; Kimchi, A. 1992: Modifications of cell cycle controlling nuclear proteins by transforming growth factor beta in the HaCaT keratinocyte cell line Oncogene 7(8): 1661-1665Hancock, J.F.; Cadwallader, K.; Paterson, H.; Marshall, C.J. 1991: A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins EMBO Journal 10(13): 4033-4039
Määttä, A.; Hutchison, C.J.; Watson, M.D. 2004: Spectraplakins and nesprins, giant spectrin repeat proteins participating in the organization of the cytoskeleton and the nuclear envelope Symposia of the Society for Experimental Biology 56: 265-277
Dubińska-Magiera, M.; Zaremba-Czogalla, M.; Rzepecki, R. 2010: Karyoskeletal and nuclear envelope proteins in cell cycle progression--known proteins in new functions Postepy Biochemii 56(4): 362-372
Christy, K.G.; LaTart, D.B.; Osterhoudt, H.W. 1989: Modifications for SDS-PAGE of proteins Biotechniques 7(7): 692-693
Malatesta, M.; Tiberi, C.; Baldelli, B.; Battistelli, S.; Manuali, E.; Biggiogera, M. 2005: Reversibility of hepatocyte nuclear modifications in mice fed on genetically modified soybean European Journal of Histochemistry: Ejh 49(3): 237-242
Kosako, H. 2015: Proteomic analyses reveal regulation of the nuclear pore complex by post-translational modifications Seikagaku. Journal of Japanese Biochemical Society 87(1): 49-55
Aguado, F.; González-Santos, P.; Escolar, J.L.; Valdivielso, P. 1989: Modifications in the composition of plasma HDLs in non-insulin-dependent diabetics Anales de Medicina Interna 6(6): 295-299
Alexa, I.D.; Foxall, P.J. 1998: Nuclear magnetic resonance spectroscopy in the diagnosis of modifications of the oxidative stress in red blood cell during pre-eclampsia Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 102(3-4): 83-88
Piacentini, M.; Ceru'-Argento, M.P.; Farrace, M.G.; Autuori, F. 1988: Post-translational modifications of cellular proteins by polyamines and polyamine-derivatives Advances in Experimental Medicine and Biology 231: 185-198
Binet, S.; Meininger, V. 1988: Modifications of microtubule proteins in ALS nerve precede detectable histologic and ultrastructural changes Neurology 38(10): 1596-1600
Demkowicz-Dobrzański, K.K.; Hennig, E.E.; Juśkiewicz-Skiba, M.; Piekarski, L. 1984: Modifications of microsomal and nuclear fractions by butylated hydroxyanisole and its effect on benzo(a)pyrene metabolites binding to macromolecules Neoplasma 31(4): 423-430
Bergonzi, P.; Chiurulla, C.; Tempesta, E. 1971: Organization of nocturnal sleep in parkinsonian patients: modifications of the phases and cycles in the course of pharmacological treatment Rivista di Neurologia 41(5): 326-334
Artiukhov, V.G.; Basharina, O.V.; Vashanov, G.A.; Nakvasina, M.A.; Putintseva, O.V. 2004: Thermal denaturation of oligomeric proteins: structural and functional modifications, the sequence of steps Biofizika 49(4): 617-630
Rucker, R.B.; McGee, C. 1993: Chemical modifications of proteins in vivo: selected examples important to cellular regulation Journal of Nutrition 123(6): 977-990
Yuan, C.; Ravi, R.; Murphy, A.M. 2005: Discovery of disease-induced post-translational modifications in cardiac contractile proteins Current Opinion in Molecular Therapeutics 7(3): 234-239
Utsumi, T. 2003: Analysis of co- and post-translational modifications of proteins by in vitro and in vivo metabolic labeling Seikagaku. Journal of Japanese Biochemical Society 75(5): 373-378
Utsumi, T. 2010: Comprehensive analysis of lipid modifications of proteins using cell-free protein synthesis system Seikagaku. Journal of Japanese Biochemical Society 82(9): 799-813
Gussio, R.; Zaharevitz, D.W.; McGrath, C.F.; Pattabiraman, N.; Kellogg, G.E.; Schultz, C.; Link, A.; Kunick, C.; Leost, M.; Meijer, L.; Sausville, E.A. 2000: Structure-based design modifications of the paullone molecular scaffold for cyclin-dependent kinase inhibition Anti-Cancer Drug Design 15(1): 53-66
Martinenghi, C. 1970: Organization of the nuclear medicine department Minerva Medica 61(80): 4430-4446